Cyhoeddiadau

Porwch ein cyhoeddiadau i ddod o hyd i erthyglau, llyfrau, adroddiadau a phapurau a ysgrifennwyd gan arbenigwyr yn eu maes.

Mae llawer o’n hymchwilwyr yn gwneud eu testun yn gwbl hygyrch er mwyn i bobl ei weld a’i rannu, gan gefnogi arloesedd ymchwil ar raddfa fyd-eang.

Cyhoeddiadau diweddar

Ahmad, S. et al., 2018. Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study. Alzheimer's and Dementia 14 (7), pp.848-857. (10.1016/j.jalz.2018.01.005)
Al-Ansari, A. and Robertson, N. P. 2018. Anti-epileptics and pregnancy: an update. Journal of Neurology 265 (11), pp.2749-2751. (10.1007/s00415-018-9058-6)
Allardyce, J. et al. 2018. Association between schizophrenia-related polygenic liability and the occurrence and level of mood-incongruent psychotic symptoms in bipolar disorder. JAMA Psychiatry 75 (1), pp.28-35. (10.1001/jamapsychiatry.2017.3485)
Alonso-Llamazares, C. et al., 2018. Medical diagnostic methods applied to a medieval female with vitamin D deficiency from the North of Spain. International Journal of Paleopathology 22 , pp.109-120. (10.1016/j.ijpp.2018.07.007)
Alsaeed, M. et al., 2018. Multiple sclerosis: long-term outcomes in ethnic minorities. analysis of a UK population-based registry. European Journal of Neurology 25 (4), pp.701-704. (10.1111/ene.13571)
Anttila, V. et al., 2018. Analysis of shared heritability in common disorders of the brain. Science 360 (6395) eaap8757. (10.1126/science.aap8757)
Arnau-Soler, A. et al., 2018. Genome-wide interaction study of a proxy for stress-sensitivity and its prediction of major depressive disorder. PLoS ONE 13 (12) e0209160. (10.1371/journal.pone.0209160)
Auvin, S. et al., 2018. Systematic review of the screening, diagnosis, and management of ADHD in children with epilepsy. Consensus paper of the Task Force on Comorbidities of the ILAE Pediatric Commission. Epilepsia 59 (10), pp.1867-1880. (10.1111/epi.14549)
Baker, E. et al. 2018. POLARIS: polygenic LD-adjusted risk score approach for set-based analysis of GWAS data. Genetic Epidemiology 42 (4), pp.366-377. (10.1002/gepi.22117)
Bakhsh, A. D. et al. 2018. An InDel in Phospholipase-C-B-1 is linked with euthyroid multinodular goiter. Thyroid 28 (7), pp.891-901. (10.1089/thy.2017.0312)
Beesley, R. et al., 2018. Impact of the 2017 revisions to McDonald criteria on the diagnosis of Multiple Sclerosis. Multiple Sclerosis 24 (13), pp.1786-1787. (10.1177/1352458518778007)
Beltrami, C. et al., 2018. Association of elevated urinary miR-126, miR-155, and miR-29b with diabetic kidney disease. American Journal of Pathology 188 (9), pp.1982-1992. (10.1016/j.ajpath.2018.06.006)
Ben-Ezra, M. et al., 2018. Posttraumatic Stress Disorder (PTSD) and Complex PTSD (CPTSD) as per ICD-11 Proposals: a population study in Israel. Depression and Anxiety 35 (3), pp.264-274. (10.1002/da.22723)
Berni, T. et al. 2018. Polycystic ovary syndrome is associated with adverse mental health and neurodevelopmental outcomes. Journal of Clinical Endocrinology and Metabolism 103 (6), pp.2116-2125. (10.1530/endoabs.50.P353)
Bevan Jones, R. et al. 2018. A web-based psychoeducational intervention for adolescent depression: design and development of MoodHwb. JMIR Mental Health 5 (1) e13. (10.2196/mental.8894)
Blokland, G. A. et al., 2018. The genetics of endophenotypes of neurofunction to understand schizophrenia (GENUS) consortium: a collaborative cognitive and neuroimaging genetics project. Schizophrenia Research 195 , pp.306-317. (10.1016/j.schres.2017.09.024)
Boot, E. et al., 2018. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2. Neurology 90 (23), pp.e2059-e2067. (10.1212/WNL.0000000000005660)
Bray, N. J. and O'Donovan, M. C. 2018. The genetics of neuropsychiatric disorders. Brain and Neuroscience Advances 2 , pp.1-6. (10.1177/2398212818799271)
Brieva, J. et al., 2018. Alternative diffusion anisotropy measures for the investigation of white matter alterations in 22q11.2 deletion syndrome. Presented at: 14th International Symposium on Medical Information Processing and Analysis, Mazatlán, Mexico 24-26 October 2018. Published in: Romero, E. , Lepore, N. and Brieva, J. eds. 14th International Symposium on Medical Information Processing and Analysis. Vol. 10975.Proceedings of SPIE Bellingham, Washington: SPIE. , pp.51. (10.1117/12.2513788)
Brikell, I. et al., 2018. The contribution of common genetic risk variants for ADHD to a general factor of childhood psychopathology. Molecular Psychiatry (10.1038/s41380-018-0109-2)
Brophy, S. et al., 2018. Characteristics of children prescribed antipsychotics: analysis of routinely collected data. Journal of Child and Adolescent Psychopharmacology 28 (3), pp.180-191. (10.1089/cap.2017.0003)
Carboni, L. et al., 2018. Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression. Neuropsychopharmacology 43 , pp.2134-2145. (10.1038/s41386-018-0117-6)
Castle, D. and Robertson, N. P. 2018. Monoclonal antibodies for migraine: an update. Journal of Neurology 265 (6), pp.1491-1492. (10.1007/s00415-018-8886-8)
Chao, M. J. et al., 2018. Population-specific genetic modification of Huntington's disease in Venezuela. PLoS Genetics 14 (5) e1007274. (10.1371/journal.pgen.1007274)
Chawner, S. J. et al. 2018. The emergence of psychotic experiences in the early adolescence of 22q11.2 Deletion Syndrome. Journal of Psychiatric Research 109 , pp.10-17. (10.1016/j.jpsychires.2018.11.002)
Chen, C. et al., 2018. Genetic validation of bipolar disorder identified by automated phenotyping using electronic health records. Translational Psychiatry 8 86. (10.1038/s41398-018-0133-7)
Clifton, N. , Thomas, K. and Hall, J. 2018. The effect of ketamine on the consolidation and extinction of contextual fear memory. Journal of Psychopharmacology 32 (2), pp.156-162. (10.1177/0269881117748903)
Cloitre, M. et al., 2018. The International Trauma Questionnaire: development of a self-report measure of ICD-11 PTSD and complex PTSD. Acta Psychiatrica Scandinavica 138 (6), pp.536-546. (10.1111/acps.12956)
Connolly, K. D. et al. 2018. Evidence for adipocyte-derived extracellular vesicles in the human circulation. Endocrinology 159 (9), pp.3259-3267. (10.1210/en.2018-00266)
Cooper, M. et al. 2018. Investigating late-onset ADHD: a population cohort investigation. Journal of Child Psychology and Psychiatry 59 (10), pp.1105-1113. (10.1111/jcpp.12911)
Corbin, L. et al., 2018. Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference. Nature Communications 9 711. (10.1038/s41467-018-03109-y)
Cosgrove, D. et al., 2018. Effects of MiR-137 genetic risk score on brain volume and cortical measures in patients with schizophrenia and controls. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 (3), pp.369-376. (10.1002/ajmg.b.32620)
Creeth, H. D. J. et al. 2018. Maternal care boosted by paternal imprinting in mammals. PLoS Biology 16 (7) e2006599. (10.1371/journal.pbio.2006599)
Cunningham, A. C. et al. 2018. Developmental coordination disorder, psychopathology and IQ in 22q11.2 deletion syndrome. British Journal of Psychiatry 212 (1), pp.27-33. (10.1192/bjp.2017.6)
Curtin, P. et al., 2018. Dynamical features in fetal and postnatal zinc-copper metabolic cycles predict the emergence of autism spectrum disorder. Science Advances 4 (5) eaat1293. (10.1126/sciadv.aat1293)
Dahoun, T. et al., 2018. The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [18F]-DOPA PET study. Human Molecular Genetics 27 (20), pp.3498-3506. (10.1093/hmg/ddy242)
Dantchev, S. , Zammit, S. and Wolke, D. 2018. Sibling bullying in middle childhood and psychotic disorder at 18 years: a prospective cohort study. Psychological Medicine 48 (14), pp.2321-2328. (10.1017/S0033291717003841)
Darlay, R. et al., 2018. Amino acid residues in five separate HLA genes can explain most of the known associations between the MHC and primary biliary cholangitis. PLoS Genetics 14 (12) e1007833. (10.1371/journal.pgen.1007833)
Davies, J. , Sullivan, S. and Zammit, S. 2018. Adverse life outcomes associated with adolescent psychotic experiences and depressive symptoms. Social Psychiatry and Psychiatric Epidemiology 53 (5), pp.497-507. (10.1007/s00127-018-1496-z)
Davies, W. 2018. Sulfation pathways: The steroid sulfate axis and its relationship to maternal behaviour and mental health. Journal of Molecular Endocrinology 61 , pp.T199-T210. (10.1530/JME-17-0219)
Davis, K. A. S. et al., 2018. Mental health in UK Biobank: development, implementation and results from an online questionnaire completed by 157 366 participants [RETRACTED]. Bjpsych Open 4 (03), pp.83-90. (10.1192/bjo.2018.12)
Dazzan, P. , Fusté, M. and Davies, W. 2018. Do defective immune system-mediated myelination processes increase postpartum psychosis risk?. Trends in Molecular Medicine 24 (11), pp.942-949. (10.1016/j.molmed.2018.09.002)
DeMichele-Sweet, M. A. A. et al., 2018. Genetic risk for schizophrenia and psychosis in Alzheimer disease. Molecular Psychiatry 23 , pp.963-972. (10.1038/mp.2017.81)
Dent, C. L. et al. 2018. Impulsive choice in mice lacking paternal expression of Grb10 suggests intragenomic conflict in behavior. Genetics 209 (1), pp.233-239. (10.1534/genetics.118.300898)
Di Florio, A. et al. 2018. Progesterone and plasma metabolites in women with and in those without premenstrual dysphoric disorder. Depression and Anxiety 35 (12), pp.1168-1177. (10.1002/da.22827)
Dimitriadis, S. and Liparas, D. 2018. How random is the random forest? Random forest algorithm on the service of structural imaging biomarkers for Alzheimer's disease: from Alzheimer's disease neuroimaging initiative (ADNI) database. Neural Regeneration Research 13 (6), pp.962-970. (10.4103/1673-5374.233433)
Dimitriadis, S. , Liparas, D. and Tsolaki, M. N. 2018. Random forest feature selection, fusion and ensemble strategy: combining multiple morphological MRI measures to discriminate among healthy elderly, MCI, cMCI and Alzheimer's disease patients: from the Alzheimer's disease neuroimaging initiative (ADNI) database. Journal of Neuroscience Methods 302 , pp.14-23. (10.1016/j.jneumeth.2017.12.010)
Dimitriadis, S. , Salis, C. and Linden, D. 2018. A novel, fast and efficient single-sensor automatic sleep-stage classification based on complementary cross-frequency coupling estimates. Clinical Neurophysiology 129 (4), pp.815-828. (10.1016/j.clinph.2017.12.039)
Dimitriadis, S. et al. 2018. Aberrant resting-state functional brain networks in dyslexia: Symbolic mutual information analysis of neuromagnetic signals. International Journal of Psychophysiology 126 , pp.20-29. (10.1016/j.ijpsycho.2018.02.008)
Doherty, J. , Cooper, M. and Thapar, A. 2018. Advances in our understanding of the genetics of childhood neurodevelopmental disorders. Evidence-Based Mental Health 21 (4), pp.171-172. (10.1136/ebmental-2018-300067)
Donohoe, G. et al., 2018. Genetically predicted complement component 4A expression: effects on memory function and middle temporal lobe activation. Psychological Medicine 48 (10), pp.1608-1615. (10.1017/S0033291717002987)
Duncan, L. E. et al., 2018. Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability. Molecular Psychiatry 23 , pp.666-673. (10.1038/mp.2017.77)
Eddowes, L. A. et al., 2018. Antiviral activity of bone morphogenetic proteins and activins. Nature Microbiology 4 , pp.339-351. (10.1038/s41564-018-0301-9)
Edwards, M. and Robertson, N. 2018. Seizures in Alzheimer's disease: is there more beneath the surface?. Journal of Neurology 265 (1), pp.226-228. (10.1007/s00415-017-8694-6)
English, J. A. et al., 2018. Blood-Based Protein Changes in Childhood Are Associated With increased risk for later psychotic disorder: evidence from a nested case–control study of the ALSPAC Longitudinal Birth Cohort. Schizophrenia Bulletin 44 (2), pp.297-306. (10.1093/schbul/sbx075)
Fabbri, C. et al., 2018. Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: meta-analysis of data from genome-wide association studies. European Neuropsychopharmacology 28 (8), pp.945-954. (10.1016/j.euroneuro.2018.05.009)
Fabbri, C. and Tansey, K. E. 2018. New insights on the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation. Pharmacogenomics Journal 18 , pp.413-421. (10.1038/tpj.2017.44)
Foley, S. F. et al. 2018. Fractional anisotropy of the uncinate fasciculus and cingulum in bipolar disorder type I, type II, their unaffected siblings and healthy controls. British Journal of Psychiatry 213 (3), pp.548-554. (10.1192/bjp.2018.101)
Forrest, M. P. et al. 2018. The psychiatric risk gene transcription factor 4 (TCF4) regulates neurodevelopmental pathways associated with schizophrenia, autism, and intellectual disability. Schizophrenia Bulletin 44 (5), pp.1100-1110. (10.1093/schbul/sbx164)
Fraser, A. et al. 2018. The presentation of depression symptoms in attention-deficit/hyperactivity disorder: comparing child and parent reports. Child and Adolescent Mental Health 23 (3), pp.243-250. (10.1111/camh.12253)
Fung, W. and Peall, K. J. 2018. Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson's disease?. Journal of Neurology 265 (10), pp.2463-2465. (10.1007/s00415-018-9046-x)
Gibson, J. A. G. et al., 2018. The association of affective disorders and facial scarring: systematic review and meta-analysis. Journal of Affective Disorders 239 , pp.1-10. (10.1016/j.jad.2018.06.013)
Gordon-Smith, K. et al., 2018. Genotype-phenotype correlations in Darier disease: A focus on the neuropsychiatric phenotype. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 (8), pp.717-726. (10.1002/ajmg.b.32679)
Guerreiro, R. et al., 2018. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurology 17 (1), pp.64-74. (10.1016/S1474-4422(17)30400-3)
Guo, T. et al., 2018. Deletion size analysis of 1680 22q11.2DS subjects identifies a new recombination hotspot on chromosome 22q11.2. Human Molecular Genetics 27 (7), pp.1150-1163. (10.1093/hmg/ddy028)
Gusareva, E. S. et al., 2018. Male-specific epistasis between WWC1 and TLN2 genes is associated with Alzheimer's disease. Neurobiology of Aging 72 , pp.e3-e12. 188. (10.1016/j.neurobiolaging.2018.08.001)
Gusev, A. et al., 2018. Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nature Genetics 50 , pp.538-548. (10.1038/s41588-018-0092-1)
Guyatt, A. L. et al., 2018. Association of copy number variation across the genome with neuropsychiatric traits in the general population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 (5), pp.489-502. (10.1002/ajmg.b.32637)
Gyöngyösi, M. et al., 2018. Meta-analysis of cell therapy studies in heart failure and acute myocardial infarction. Circulation Research 123 (2), pp.301-308. (10.1161/CIRCRESAHA.117.311302)
Harding, K. et al. 2018. A contemporary study of mortality in the multiple sclerosis population of south east Wales. Multiple Sclerosis and Related Disorders 25 , pp.186-191. (10.1016/j.msard.2018.08.001)
Hay, D. F. et al. 2018. Seven-year-olds' aggressive choices in a computer game can be predicted in infancy. Developmental Science 21 (3) e12576. (10.1111/desc.12576)
Hidalgo-Mazzei, D. et al., 2018. Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: consensus definition. British Journal of Psychiatry (10.1192/bjp.2018.257)
Hoare, T. , Vidgen, A. and Roberts, N. 2018. In their own words: a synthesis of the qualitative research on the experiences of adults seeking asylum. a systematic review of qualitative findings in forced migration. Medicine, Conflict and Survival 33 (4), pp.273. (10.1080/13623699.2017.1419902)
Holmans, P. and Stone, T. 2018. Using genomic data to find disease-modifying loci in Huntington's Disease (HD). In: Precious, S. V. , Rosser, A. E. and Dunnett, S. eds. Huntington’s Disease. Vol. 1780, Methods in Molecular Biology Humana Press. , pp.443-461. (10.1007/978-1-4939-7825-0_20)
Hu, M. and Robertson, N. P. 2018. Transmissible amyloid protein: evidence from iatrogenic CJD. Journal of Neurology 265 (7), pp.1726-1729. (10.1007/s00415-018-8927-3)
John, A. et al. 2018. Premature mortality among people with severe mental illness - new evidence from linked primary care data. Schizophrenia Research 199 , pp.154-162. (10.1016/j.schres.2018.04.009)
Jones, H. J. et al., 2018. Association of combined patterns of tobacco and cannabis use in adolescence with psychotic experiences. JAMA Psychiatry 75 (3), pp.240-246. (10.1001/jamapsychiatry.2017.4271)
Jones, H. J. et al., 2018. Investigating the genetic architecture of general and specific psychopathology in adolescence. Translational Psychiatry 8 (1) 145. (10.1038/s41398-018-0204-9)
Kamath, A. et al., 2018. Chromosome 17q12 duplications: Further delineation of the range of psychiatric and clinical phenotypes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 (5), pp.520-528. (10.1002/ajmg.b.32643)
Karatzias, T. et al., 2018. PTSD and Complex PTSD: ICD-11 updates on concept and measurement in the UK, USA, Germany and Lithuania. European Journal of Psychotraumatology 8 (sup7) 1418103. (10.1080/20008198.2017.1418103)
Karatzias, T. et al., 2018. The role of negative cognitions, emotion regulation strategies, and attachment style in complex post-traumatic stress disorder: implications for new and existing therapies. British Journal of Clinical Psychology 57 (2), pp.177-185. (10.1111/bjc.12172)
Kerr, M. et al. 2018. The provision of care to adults with an intellectual disability in the UK. A Special report from the intellectual disability UK chapter ILAE. Seizure - European Journal of Epilepsy 56 , pp.41-46. (10.1016/j.seizure.2018.01.026)
Khandaker, G. M. et al., 2018. Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort. Brain, Behavior, and Immunity 69 , pp.264-272. (10.1016/j.bbi.2017.11.020)
Lacey, A. S. et al., 2018. Educational attainment of children born to mothers with epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 89 (7), pp.736-740. (10.1136/jnnp-2017-317515)
Lancaster, T. et al. 2018. Preliminary evidence for genetic overlap between body mass index and striatal reward response. Translational Psychiatry 8 19. (10.1038/s41398-017-0068-4)
Lanzillo, R. et al., 2018. A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study. Journal of Neurology 265 (5), pp.1174-1183. (10.1007/s00415-018-8831-x)
Lawrence, D. et al., 2018. External validity and anchoring heuristics: application of DUNDRUM-1 to secure service gatekeeping in South Wales. BJPsych Bulletin 42 (01), pp.10-18. (10.1192/bjb.2017.6)
Lawton, M. et al., 2018. Developing and validating Parkinson's disease subtypes and their motor and cognitive progression. Journal of Neurology, Neurosurgery and Psychiatry 89 (12), pp.1279-1287. (10.1136/jnnp-2018-318337)
Leonenko, G. et al. 2018. A data-driven investigation of relationships between bipolar psychotic symptoms and schizophrenia genome-wide significant genetic loci. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 (4), pp.468-475. (10.1002/ajmg.b.32635)
Lewis, K. et al., 2018. Mania triggered by sleep loss and risk of postpartum psychosis in women with bipolar disorder. Journal of Affective Disorders 225 , pp.624-629. (10.1016/j.jad.2017.08.054)
Li, M. et al., 2018. Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science 362 (6420) eaat7615. (10.1126/science.aat7615)
Loveless, S. et al. 2018. Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis. Brain Pathology 28 (4), pp.507-520. (10.1111/bpa.12546)
Lynham, A. et al. 2018. Examining cognition across the bipolar / schizophrenia diagnostic spectrum. Journal of Psychiatry and Neuroscience 43 (3) 170076. (10.1503/jpn.170076)
Macare, C. et al., 2018. A neurobiological pathway to smoking in adolescence: TTC12-ANKK1-DRD2 variants and reward response. European Neuropsychopharmacology 28 (10)(10.1016/j.euroneuro.2018.07.101)
Mahedy, L. et al. 2018. Resilience in high-risk adolescents of mothers with recurrent depressive disorder: the contribution of fathers. Journal of Adolescence 65 , pp.207-218. (10.1016/j.adolescence.2018.03.016)
Malek, N. et al., 2018. Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study. Journal of Neurology, Neurosurgery and Psychiatry 89 (7), pp.702-709. (10.1136/jnnp-2017-317348)
Malki, K. et al., 2018. Identification of genes and gene pathways associated with major depressive disorder by integrative brain analysis of rat and human prefrontal cortex transcriptomes. Translational Psychiatry 5 (3) e519. (10.1038/tp.2015.15)
Manjunath, A. et al., 2018. Serving a community sentence with a mental health treatment requirement: Offenders' perspectives. Criminal Behaviour and Mental Health 28 (6), pp.492-502. (10.1002/cbm.2096)
Martin, J. et al. 2018. Copy number variation and neuropsychiatric problems in females and males in the general population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 180 (6), pp.341-350. (10.1002/ajmg.b.32685)
Martin, J. , Taylor, M. J. and Lichtenstein, P. 2018. Assessing the evidence for shared genetic risks across psychiatric disorders and traits. Psychological Medicine 48 (11), pp.1759-1774. (10.1017/S0033291717003440)
Martin, J. et al. 2018. Sex-specific manifestation of genetic risk for attention deficit hyperactivity disorder in the general population. Journal of Child Psychology and Psychiatry 59 (8), pp.908-916. (10.1111/jcpp.12874)
Martin, J. et al. 2018. A genetic investigation of sex bias in the prevalence of attention-deficit/hyperactivity disorder. Biological Psychiatry 83 (12), pp.1044-1053. (10.1016/j.biopsych.2017.11.026)
Massey, T. and Jones, L. 2018. The central role of DNA damage and repair in CAG repeat diseases. Disease Models & Mechanisms 11 (1) dmm031930. (10.1242/dmm.031930)
Massey, T. , McAllister, B. and Jones, L. 2018. Methods for assessing DNA repair and repeat expansion in Huntington's Disease. In: Precious, S. V. , Rosser, A. E. and Dunnett, S. B. eds. Huntington’s Disease. Vol. 1780, Methods in Molecular Biology Humana Press. , pp.483-495. (10.1007/978-1-4939-7825-0_22)
Massey, T. and Robertson, N. 2018. Repurposing drugs to treat neurological diseases. Journal of Neurology 265 (2), pp.446-448. (10.1007/s00415-018-8732-z)
McColgan, P. et al., 2018. Brain regions showing white matter loss in Huntington's Disease are enriched for synaptic and metabolic genes. Biological Psychiatry 83 (5), pp.456-465. (10.1016/j.biopsych.2017.10.019)
McLauchlan, D. and Robertson, N. P. 2018. Stem cells in the treatment of central nervous system disease. Journal of Neurology 265 (4), pp.984-986. (10.1007/s00415-018-8818-7)
McNamara, G. I. et al. 2018. Loss of offspring Peg3 reduces neonatal ultrasonic vocalizations and increases maternal anxiety in wild-type mothers. Human Molecular Genetics 27 (3), pp.440-450. (10.1093/hmg/ddx412)
McNamara, G. I. et al. 2018. Dopaminergic and behavioral changes in a loss-of-imprinting model of Cdkn1c. Genes, Brain and Behavior 17 (2), pp.149-157. (10.1111/gbb.12422)
McNamara, G. , John, R. and Isles, A. 2018. Territorial behaviour and social stability in the mouse require correct expression of imprinted Cdkn1c. Frontiers in Behavioral Neuroscience 12 28. (10.3389/fnbeh.2018.00028)
McNulty, P. et al., 2018. Reduced cancer incidence in Huntington's disease: analysis in the Registry study. Journal of Huntington's Disease 7 (3), pp.209-222. (10.3233/JHD-170263)
Mehler, D. M. A. et al. 2018. Targeting the affective brain - a randomized controlled trial of real-time fMRI neurofeedback in patients with depression. Neuropsychopharmacology 43 , pp.2578-2585. (10.1038/s41386-018-0126-5)
Meltzer-Brody, S. et al., 2018. Adverse life events increase risk for postpartum psychiatric episodes: a population based epidemiologic study. Depression and Anxiety 35 (2), pp.160-167. (10.1002/da.22697)
Meltzer-Brody, S. et al., 2018. Postpartum psychiatric disorders. Nature Reviews Disease Primers 4 18022. (10.1038/nrdp.2018.22)
Mistry, S. et al. 2018. The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: systematic review. Schizophrenia Research 197 , pp.2-8. (10.1016/j.schres.2017.10.037)
Mistry, S. et al. 2018. The use of polygenic risk scores to identify phenotypes associated with genetic risk of bipolar disorder and depression: A systematic review. Journal of Affective Disorders 234 , pp.148-155. (10.1016/j.jad.2018.02.005)
Mollon, J. et al., 2018. Course of cognitive development from infancy to early adulthood in the psychosis spectrum. JAMA Psychiatry 75 (3), pp.270-279. (10.1001/jamapsychiatry.2017.4327)
Mollon, J. , Zammit, S. and Reichenberg, A. 2018. Clinical implications of slower cognitive growth in the psychosis spectrum-reply. JAMA Psychiatry 75 (7), pp.756-757. (10.1001/jamapsychiatry.2018.0816)
Moon, A. L. et al. 2018. CACNA1C: Association with pychiatric disorders, behavior, and neurogenesis. Schizophrenia Bulletin 44 (5), pp.958-965. (10.1093/schbul/sby096)
Morrison, S. et al. 2018. Vulnerable periods for cognitive development in individuals at high genomic risk of schizophrenia [Conference Abstract]. Schizophrenia Bulletin 44 (suppl), pp.S86. (10.1093/schbul/sby015.214)
Munk-Olsen, T. et al., 2018. Maternal and infant outcomes associated with lithium use in pregnancy. Lancet Psychiatry 5 (8), pp.644-652. (10.1016/S2215-0366(18)30180-9)
Ng-Knight, T. et al., 2018. Maternal depressive symptoms and adolescent academic attainment: Testing pathways via parenting and self-control. Journal of Adolescence 62 , pp.61-69. (10.1016/j.adolescence.2017.11.003)
Niarchou, M. et al. 2018. Attention deficit hyperactivity disorder symptoms and psychosis in 22q11.2 deletion syndrome. Schizophrenia Bulletin 44 (4), pp.824-833. (10.1093/schbul/sbx113)
O'Brien, H. E. et al. 2018. Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders. Genome Biology 19 194. (10.1186/s13059-018-1567-1)
Owen, D. et al. 2018. Effects of pathogenic CNVs on physical traits in participants of the UK Biobank. BMC Genomics 19 (1) 867. (10.1186/s12864-018-5292-7)
Pardinas, A. F. et al. 2018. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nature Genetics 50 , pp.381-389. (10.1038/s41588-018-0059-2)
Pariani, N. et al., 2018. Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features. Journal of Clinical Endocrinology & Metabolism 108 (8), pp.3010-3018. (10.1210/jc.2018-00359)
Patel, C. K. et al., 2018. Trends in peri-operative performance status following resection of high grade glioma and brain metastases: The impact on survival. Clinical Neurology and Neurosurgery 164 , pp.67-71. (10.1016/j.clineuro.2017.11.016)
Pickrell, W. O. and Robertson, N. P. 2018. New treatments in Alzheimer's disease. Journal of Neurology 265 (9), pp.2162-2163. (10.1007/s00415-018-9018-1)
Pratt, J. and Hall, J. 2018. Biomarkers in neuropsychiatry: a prospect for the twenty-first century?. Current Topics in Behavioral Neuroscience 40 , pp.3-10. (10.1007/7854_2018_58)
Price, C. et al., 2018. Association of residential mobility over the life course with nonaffective psychosis in 1.4 million young people in Sweden. JAMA Psychiatry 75 (11), pp.1128-1136. (10.1001/jamapsychiatry.2018.2233)
Putkonen, H. and Taylor, P. 2018. Making sense of mental health service changes. Nordic Journal of Psychiatry 72 (2), pp.82-83. (10.1080/08039488.2017.1398275)
Rahman, M. A. et al., 2018. School achievement as a predictor of depression and self-harm in adolescence: linked education and health record study. British Journal of Psychiatry 212 (04), pp.215-221. (10.1192/bjp.2017.69)
Rai, D. et al., 2018. Association of autistic traits with depression from childhood to age 18 years. JAMA Psychiatry 75 (8), pp.835-843. (10.1001/jamapsychiatry.2018.1323)
Rao, S. et al., 2018. An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk. Neurobiology of Aging 66 , pp.178-178. e1-e8. (10.1016/j.neurobiolaging.2017.12.027)
Reddaway, J. et al. 2018. Genomic and imaging biomarkers in schizophrenia. In: Current Topics in Behavioral Neurosciences. Berlin and Heidelberg: Springer. , pp.325-352. (10.1007/7854_2018_52)
Rees, D. A. 2018. Tips from the shop floor: Addisonian crisis - assessment and management. British Journal of Hospital Medicine 79 (3), pp.34-37. (10.12968/hmed.2018.79.3.C34)
Rice, F. et al. 2018. Identifying the contribution of prenatal risk factors to offspring development and psychopathology: What designs to use and a critique of literature on maternal smoking and stress in pregnancy. Development and Psychopathology 30 (03), pp.1107-1128. (10.1017/S0954579418000421)
Richards, G. et al., 2018. 2D:4D digit ratio and religiosity in university student and general population samples. Transpersonal Psychology Review 20 (1), pp.23-36.
Riglin, L. et al. 2018. The impact of schizophrenia and mood disorder risk alleles on emotional problems: investigating change from childhood to middle age. Psychological Medicine 48 (13), pp.2153-2158. (10.1017/S0033291717003634)
Roberts, L. et al., 2018. Qualitative exploration of the effect of a television soap opera storyline on women with experience of postpartum psychosis. Bjpsych Open 4 (02), pp.75-82. (10.1192/bjo.2018.9)
Robertson, J. and Tallantyre, E. 2018. Nerve sheath tumours. Journal of Neurology 265 (12), pp.3034-3035. (10.1007/s00415-018-9098-y)
Rodríguez-López, J. et al., 2018. Identification of putative second genetic hits in schizophrenia carriers of high-risk copy number variants and resequencing in additional samples. European Archives of Psychiatry and Clinical Neuroscience 268 (6), pp.585-592. (10.1007/s00406-017-0799-5)
Ruderfer, D. M. et al., 2018. Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes. Cell 173 (7), pp.1705-1715.e16. (10.1016/j.cell.2018.05.046)
Salavert, J. et al., 2018. Functional imaging changes in the medial prefrontal cortex in adult ADHD. Journal of Attention Disorders 22 (7), pp.679-693. (10.1177/1087054715611492)
Sharouf, F. et al. 2018. Neurocutaneous melanosis presenting with hydrocephalus & malignant transformation: case base update. Child's Nervous System 34 (8), pp.1471-1477. (10.1007/s00381-018-3851-5)
Shevlin, M. et al., 2018. A comparison of DSM-5 and ICD-11 PTSD prevalence, comorbidity and disability: an analysis of the Ukrainian Internally Displaced Person's Mental Health Survey. Acta Psychiatrica Scandinavica 137 (2), pp.138-147. (10.1111/acps.12840)
Shevlin, M. et al., 2018. A psychometric assessment of disturbances in self-organization symptom indicators for ICD-11 complex PTSD using the International Trauma Questionnaire. European Journal of Psychotraumatology 9 (1) 1419749. (10.1080/20008198.2017.1419749)
Shtaya, A. et al., 2018. AMPA receptors and seizures mediate hippocampal radial glia-like stem cell proliferation. GLIA 66 (11), pp.2397-2413. (10.1002/glia.23479)
Silverdale, M. A. et al., 2018. A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease. Parkinsonism & Related Disorders 56 , pp.27-32. (10.1016/j.parkreldis.2018.06.001)
Sims, R. et al. 2018. Meta-analysis of genetic association with diagnosed Alzheimer's disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing. [Online].bioRxiv. (10.1101/294629)Available at: https://doi.org/10.1101/294629.
Skene, N. G. et al., 2018. Genetic identification of brain cell types underlying schizophrenia. Nature Genetics 50 , pp.825-833. (10.1038/s41588-018-0129-5)
Strawbridge, R. J. et al., 2018. Genome-wide analysis of self-reported risk-taking behaviour and cross-disorder genetic correlations in the UK Biobank cohort. Translational Psychiatry 8 39. (10.1038/s41398-017-0079-1)
Strawbridge, R. J. et al., 2018. Genetics of self-reported risk-taking behaviour, trans-ethnic consistency and relevance to brain gene expression. Translational Psychiatry 8 (1) 178. (10.1038/s41398-018-0236-1)
Tallantyre, E. et al. 2018. Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation. Journal of Neurology 265 (5), pp.1115-1122. (10.1007/s00415-018-8812-0)
Tallantyre, E. C. et al. 2018. How common is truly benign MS in a UK population?. Journal of Neurology, Neurosurgery and Psychiatry 90 , pp.522-528. (10.1136/jnnp-2018-318802)
Tansey, K. E. , Cameron, D. and Hill, M. J. 2018. Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks. Genome Medicine 10 14. (10.1186/s13073-018-0523-8)
Tansey, K. E. and Hill, M. J. 2018. Enrichment of schizophrenia heritability in both neuronal and glia cell regulatory elements. Translational Psychiatry 8 7. (10.1038/s41398-017-0053-y)
Taylor, A. E. et al., 2018. Exploring the association of genetic factors with participation in the Avon longitudinal study of parents and children. International Journal of Epidemiology 47 (4), pp.1207-1216. dyy060. (10.1093/ije/dyy060)
Taylor, P. and Kalebic, N. 2018. Psychosis and homicide. Current Opinion in Psychiatry 31 (3), pp.223-230. (10.1097/YCO.0000000000000411)
Telezhkin, V. et al. 2018. Kv7 channels are upregulated during striatal neuron development and promote maturation of human iPSC-derived neurons. Pflügers Archiv European Journal of Physiology 470 (9), pp.1359-1376. (10.1007/s00424-018-2155-7)
Thapar, A. 2018. Discoveries on the genetics of ADHD in the 21st century: new findings and their implications. American Journal of Psychiatry 175 (10), pp.943-950. (10.1176/appi.ajp.2018.18040383)
Thomas, R. 2018. Valproate: life-saving, life-changing. Clinical Medicine 18 (S2), pp.s1-s8. (10.7861/clinmedicine.18-2-s1)
Thompson, C. , Vidgen, A. and Roberts, N. 2018. Psychological interventions for post-traumatic stress disorder in refugees and asylum seekers: a systematic review and meta-analysis. Clinical Psychology Review 63 , pp.66-79. (10.1016/j.cpr.2018.06.006)
Tomassini, V. et al. 2018. Predicting the profile of increasing disability in multiple sclerosis. Multiple Sclerosis 25 (9), pp.1306-1315. (10.1177/1352458518790397)
Ved, R. et al. 2018. Pituitary xanthogranulomas: clinical features, radiological appearances and post-operative outcomes. Pituitary 21 (3), pp.256-265. (10.1007/s11102-017-0859-x)
White, E. K. et al., 2018. Twin classroom dilemma: To study together or separately?. Developmental Psychology 54 (7), pp.1244-1254. (10.1037/dev0000519)
Willis, M. D. and Robertson, N. P. 2018. Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease. Journal of Neurology 265 (8), pp.1950-1952. (10.1007/s00415-018-8963-z)
Willis, M. D. et al. 2018. Sarcoidosis following alemtuzumab treatment for multiple sclerosis. Multiple Sclerosis 24 (13), pp.1779-`782. (10.1177/1352458518790391)
Wray, N. R. et al., 2018. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nature Genetics 50 (5), pp.668-681. (10.1038/s41588-018-0090-3)
Zacharopoulos, G. et al. 2018. The effect of self-focus on personal and social foraging behaviour. Social Cognitive and Affective Neuroscience 13 (9), pp.967-975. (10.1093/scan/nsy057)
Zahova, S. and Isles, A. 2018. The role of the Prader-Willi syndrome critical interval for epigenetic regulation, transcription and phenotype. Epigenomes 2 (4) 18. (10.3390/epigenomes2040018)
Zammit, S. et al. 2018. Undetected post-traumatic stress disorder in secondary-care mental health services: systematic review. British Journal of Psychiatry 212 (1), pp.11-18. (10.1192/bjp.2017.8)
Zhao, Y. et al., 2018. Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects. American Journal of Medical Genetics Part A 176 (10), pp.2172-2181. (10.1002/ajmg.a.40359)
Zutt, R. et al., 2018. Electrophysiologic testing aids diagnosis and subtyping of myoclonus. Neurology 90 (8), pp.e647-e657. (10.1212/WNL.0000000000004996)

Cyhoeddiadau

Cyhoeddiadau diweddar

Archif cyhoeddiadau

Canolfan ar gyfer Geneteg a Genomeg Niwroseiciatrig

Cysylltwch â ni

Ymweld â Chanolfan ar gyfer Geneteg a Genomeg Niwroseiciatrig